Patent assignee · SE · COMPANY

Clanotech AB

3Patents
3Active
3Granted
40Portfolio score

Filing activity: Nov 14, 2008 → Aug 30, 2013 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8957092B2 Quinoline derivatives and their use as tyrosine kinase inhibitors Human Necessities 1 Active
US8557843B2 Quinoline derivatives and their use as tyrosine kinase inhibitors Human Necessities 1 Active
US9376393B2 Quinoline compounds which are anti-angiogenic integrin alpha5 beta1 inhibitors for use in the treatment of fibrosis or fibrosis-related diseases Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.